Lessons on the use of real-world data in medical device research: findings from the National Evaluation System for Health Technology Test-Cases
Journal of Comparative Effectiveness Research · 2024
DOI: 10.57264/cer-2024-0078 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Comparative Effectiveness Research, 2024. Verfasst von Justin W Timbie und 4 weiteren Autor:innen. Beteiligte Einrichtung: RAND, Arlington, VA 22202, USA. Hauptthemen laut MEDLINE: United States Food and Drug Administration, Technology Assessment, Biomedical. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: FDA HHS.
Abstract (Originalsprache)
Aim
Although the US FDA encourages manufacturers of medical devices to submit real-world evidence (RWE) to support regulatory decisions, the ability of real-world data (RWD) to generate evidence suitable for decision making remains unclear. The 2017 Medical Device User Fee Amendments (MDUFA IV), authorized the National Evaluation System for health Technology Coordinating Center (NESTcc) to conduct pilot projects, or ‘Test-Cases’, to assess whether current RWD captures the information needed to answer research questions proposed by industry stakeholders. We synthesized key lessons about the challenges conducting research with RWD and the strategies used by research teams to enhance their ability to generate evidence from RWD based on 18 Test-Cases conducted between 2020 and 2022. Materials & methods: We reviewed study protocols and reports from each Test-Case team and conducted 49 semi-structured interviews with representatives of participating organizations. Interview transcripts were coded and thematically analyzed.
Results
Challenges that stakeholders encountered in working with RWD included the lack of unique device identifiers, capturing key data elements and their appropriate meaning in structured data, limited reliability of diagnosis and procedure codes in structured data, extracting information from unstructured electronic health record (EHR) data, limited capture of long-term study end points, missing data and data sharing. Successful strategies included using manufacturer and supply chain data, leveraging clinical registries and registry reporting processes to collect and aggregate data, querying standardized EHR data, implementing natural language processing algorithms and using multidisciplinary research teams.
Conclusion
The Test-Cases identified numerous challenges working with RWD but also opportunities to address these challenges and improve researchers' ability to use RWD to generate evidence on medical devices.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- RAND, Arlington, VA 22202, USA.
- RAND, Santa Monica, CA 90401, USA.
- RAND, Boston, MA 02116, USA.
- RAND, Pittsburgh, PA 15213, USA.
ORCID-Profile: Justin W Timbie, Lawrence Baker, Thomas W Concannon
Förderung
- FDA HHS
Zitieren
APA
Timbie, J. W., Kim, A. Y., Baker, L., Li, R., & W Concannon, T. (2024). Lessons on the use of real-world data in medical device research: findings from the National Evaluation System for Health Technology Test-Cases. Journal of Comparative Effectiveness Research. https://doi.org/10.57264/cer-2024-0078
Vancouver
Timbie JW, Kim AY, Baker L, Li R, W Concannon T. Lessons on the use of real-world data in medical device research: findings from the National Evaluation System for Health Technology Test-Cases. Journal of Comparative Effectiveness Research. 2024. doi:10.57264/cer-2024-0078
BibTeX
@article{Timbie2024,
author = {Timbie, Justin W and Kim, Alice Y and Baker, Lawrence and Li, Rosemary and W Concannon, Thomas},
title = {Lessons on the use of real-world data in medical device research: findings from the National Evaluation System for Health Technology Test-Cases},
journal = {Journal of Comparative Effectiveness Research},
year = {2024},
doi = {10.57264/cer-2024-0078}
}
EUVIMED